Search
Transcode Therapeutics Inc
RNAZAdd to Watchlist
1.770USD
+0.010+0.57%
Close 09-22 16:00（ET）
1.88MMarket Cap
LossP/E TTM
RNAZ Financials
See Transcode Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
1.88M
Dividend TTM
0.00
P/E TTM
-0.47
EPS TTM
-3.71
Revenue
--
Net Profit
-16.82M
ROE
-757.04%
ROA
-47.38%
Transcode Therapeutics Inc Earnings Date
Latest Release
Aug 14, 2026
EPS / Forecast
-7.17/--
Revenue / Forecast
--/--
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its current assets were 21.98M, with a year-on-year change of 209.92.
What are the total assets of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total assets of Transcode Therapeutics Inc were 162.40M, with a year-on-year change of 2126.32.
What are the total liabilities of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total liabilities of Transcode Therapeutics Inc were 10.52M, with a year-on-year change of 12.94.
What is the total equity of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total equity of Transcode Therapeutics Inc was 151.88M, with a year-on-year change of 7623.53.
What is the net operating income of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net operating income of Transcode Therapeutics Inc was -17.92M, with a year-on-year change of -18.36.
What is the net investment of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net investment of Transcode Therapeutics Inc was -4.44K, with a year-on-year change of 79.61.
What is the net financing of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net financing of Transcode Therapeutics Inc was 31.52M, with a year-on-year change of 92.20.
What is the Earnings Per Share (EPS) of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -52.59, with a year-on-year change of 96.02.
What is the net income of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net income was -36.27M, with a year-on-year change of -115.69.
What is the Return on Assets (ROA) of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -40.85, with a year-on-year change of 84.81.
What is the operating profit of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its operating profit was -17.92M, with a year-on-year change of -18.36.